Ferumoxytol Patent Expiration

Ferumoxytol is Used for treating iron deficiency in patients. It was first introduced by Covis Pharma Gmbh in its drug Feraheme on Jun 30, 2009. 2 different companies have introduced drugs containing Ferumoxytol.


Ferumoxytol Patents

Given below is the list of patents protecting Ferumoxytol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Feraheme US6599498 Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives Mar 08, 2020

(Expired)

Covis
Feraheme US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof Mar 08, 2020

(Expired)

Covis
Feraheme US7871597 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis
Feraheme US8501158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis
Feraheme US8591864 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis
Feraheme US8926947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis



Ferumoxytol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ferumoxytol Generic API Manufacturers

Only one generic application has been filed for Ferumoxytol.

Given below is the list of companies who have filed for Ferumoxytol generic, along with the locations of their manufacturing plants worldwide.